[1]
Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. Journal of neurology, neurosurgery, and psychiatry. 2014 Feb:85(2):168-73. doi: 10.1136/jnnp-2013-305979. Epub 2013 Aug 26
[PubMed PMID: 23978380]
Level 3 (low-level) evidence
[2]
Wenz H, Eisele P, Artemis D, Förster A, Brockmann MA. Acute Marchiafava-Bignami disease with extensive diffusion restriction and early recovery: case report and review of the literature. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2014 Jul-Aug:24(4):421-4. doi: 10.1111/j.1552-6569.2012.00755.x. Epub 2012 Dec 17
[PubMed PMID: 23253188]
Level 3 (low-level) evidence
[3]
Matsuura H, Shindo K. Marchiafava-Bignami disease. QJM : monthly journal of the Association of Physicians. 2018 Oct 1:111(10):755. doi: 10.1093/qjmed/hcy101. Epub
[PubMed PMID: 29788472]
[4]
Hoshino Y, Ueno Y, Shimura H, Miyamoto N, Watanabe M, Hattori N, Urabe T. Marchiafava-Bignami disease mimics motor neuron disease: case report. BMC neurology. 2013 Dec 21:13():208. doi: 10.1186/1471-2377-13-208. Epub 2013 Dec 21
[PubMed PMID: 24359465]
Level 3 (low-level) evidence
[5]
Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Archives of neurology. 1998 Feb:55(2):193-8
[PubMed PMID: 9482361]
[6]
Wiegmann C, Mick I, Brandl EJ, Heinz A, Gutwinski S. Alcohol and Dementia - What is the Link? A Systematic Review. Neuropsychiatric disease and treatment. 2020:16():87-99. doi: 10.2147/NDT.S198772. Epub 2020 Jan 9
[PubMed PMID: 32021202]
Level 1 (high-level) evidence
[7]
Kapogiannis D, Kisser J, Davatzikos C, Ferrucci L, Metter J, Resnick SM. Alcohol consumption and premotor corpus callosum in older adults. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2012 Oct:22(10):704-10. doi: 10.1016/j.euroneuro.2012.02.003. Epub 2012 Mar 6
[PubMed PMID: 22401959]
[8]
Fernandes LMP, Bezerra FR, Monteiro MC, Silva ML, de Oliveira FR, Lima RR, Fontes-Júnior EA, Maia CSF. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity: how poor nutrition contributes to the alcoholic syndrome, as Marchiafava-Bignami disease. European journal of clinical nutrition. 2017 May:71(5):580-586. doi: 10.1038/ejcn.2016.267. Epub 2017 Feb 22
[PubMed PMID: 28225048]
[9]
Suzuki Y, Oishi M, Ogawa K, Kamei S. A patient with Marchiafava-Bignami disease as a complication of diabetes mellitus treated effectively with corticosteroid. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2012 May:19(5):761-2. doi: 10.1016/j.jocn.2011.07.040. Epub 2012 Feb 9
[PubMed PMID: 22325074]
[10]
Bachar M, Fatakhov E, Banerjee C, Todnem N. Rapidly Resolving Nonalcoholic Marchiafava-Bignami Disease in the Setting of Malnourishment After Gastric Bypass Surgery. Journal of investigative medicine high impact case reports. 2018 Jan-Dec:6():2324709618784318. doi: 10.1177/2324709618784318. Epub 2018 Jun 28
[PubMed PMID: 30083556]
Level 3 (low-level) evidence
[11]
Boutboul D, Lidove O, Aguilar C, Klein I, Papo T. Marchiafava-Bignami disease complicating SC hemoglobin disease and Plasmodium falciparum infection. Presse medicale (Paris, France : 1983). 2010 Sep:39(9):990-3. doi: 10.1016/j.lpm.2010.02.052. Epub 2010 May 26
[PubMed PMID: 20537852]
[12]
Cui Y, Zheng L, Wang X, Zhang W, Yuan D, Wei Y. Marchiafava-Bignami disease with rare etiology: A case report. Experimental and therapeutic medicine. 2015 Apr:9(4):1515-1517
[PubMed PMID: 25780461]
Level 3 (low-level) evidence
[13]
Pérez Álvarez AI, Ramón Carbajo C, Morís de la Tassa G, Pascual Gómez J. Marchiafava-Bignami disease triggered by poorly controlled diabetes mellitus. Neurologia (Barcelona, Spain). 2016 Sep:31(7):498-500. doi: 10.1016/j.nrl.2015.01.001. Epub 2015 Feb 26
[PubMed PMID: 25728951]
[14]
Estruch R, Nicolás JM, Salamero M, Aragón C, Sacanella E, Fernández-Solà J, Urbano-Márquez A. Atrophy of the corpus callosum in chronic alcoholism. Journal of the neurological sciences. 1997 Mar 10:146(2):145-51
[PubMed PMID: 9077511]
[15]
Yadala S, Luo JJ. Marchiafava-bignami disease in a nonalcoholic diabetic patient. Case reports in neurological medicine. 2013:2013():979383. doi: 10.1155/2013/979383. Epub 2013 Apr 24
[PubMed PMID: 23710388]
Level 3 (low-level) evidence
[16]
Ceylan-Isik AF, McBride SM, Ren J. Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication? Life sciences. 2010 Jul 31:87(5-6):133-8. doi: 10.1016/j.lfs.2010.06.002. Epub 2010 Jun 16
[PubMed PMID: 20598716]
[17]
Khan S, Okuda M, Hasin DS, Secades-Villa R, Keyes K, Lin KH, Grant B, Blanco C. Gender differences in lifetime alcohol dependence: results from the national epidemiologic survey on alcohol and related conditions. Alcoholism, clinical and experimental research. 2013 Oct:37(10):1696-705. doi: 10.1111/acer.12158. Epub 2013 Jun 13
[PubMed PMID: 23763329]
Level 3 (low-level) evidence
[18]
Garcia-Santibanez R. Marchiafava-Bignami disease presenting as acute dysarthria and ataxia. Alcohol and alcoholism (Oxford, Oxfordshire). 2015 Mar:50(2):256-7. doi: 10.1093/alcalc/agu093. Epub 2014 Dec 22
[PubMed PMID: 25534932]
[19]
Helenius J, Tatlisumak T, Soinne L, Valanne L, Kaste M. Marchiafava-Bignami disease: two cases with favourable outcome. European journal of neurology. 2001 May:8(3):269-72
[PubMed PMID: 11328337]
Level 3 (low-level) evidence
[20]
He X, Sullivan EV, Stankovic RK, Harper CG, Pfefferbaum A. Interaction of thiamine deficiency and voluntary alcohol consumption disrupts rat corpus callosum ultrastructure. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2007 Oct:32(10):2207-16
[PubMed PMID: 17299515]
[21]
Warden AS, Mayfield RD. Gene expression profiling in the human alcoholic brain. Neuropharmacology. 2017 Aug 1:122():161-174. doi: 10.1016/j.neuropharm.2017.02.017. Epub 2017 Mar 15
[PubMed PMID: 28254370]
[22]
Manzo-Avalos S, Saavedra-Molina A. Cellular and mitochondrial effects of alcohol consumption. International journal of environmental research and public health. 2010 Dec:7(12):4281-304. doi: 10.3390/ijerph7124281. Epub 2010 Dec 21
[PubMed PMID: 21318009]
[23]
Spector R. Thiamin homeostasis in the central nervous system. Annals of the New York Academy of Sciences. 1982:378():344-54
[PubMed PMID: 7044228]
[24]
Osiezagha K, Ali S, Freeman C, Barker NC, Jabeen S, Maitra S, Olagbemiro Y, Richie W, Bailey RK. Thiamine deficiency and delirium. Innovations in clinical neuroscience. 2013 Apr:10(4):26-32
[PubMed PMID: 23696956]
[25]
Singleton CK, Martin PR. Molecular mechanisms of thiamine utilization. Current molecular medicine. 2001 May:1(2):197-207
[PubMed PMID: 11899071]
[26]
Al-Witri A, Vialatte AL, Tan KL, Dexter MAJ. Antemortem histopathology and imaging findings in a case of Marchiafava-Bignami disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2019 Aug:66():273-275. doi: 10.1016/j.jocn.2019.05.009. Epub 2019 Jun 6
[PubMed PMID: 31178304]
Level 3 (low-level) evidence
[27]
Weis S, Büttner A. Alcohol-related diseases. Handbook of clinical neurology. 2017:145():175-180. doi: 10.1016/B978-0-12-802395-2.00013-4. Epub
[PubMed PMID: 28987168]
[28]
Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava-Bignami disease. Journal of neurology. 2004 Sep:251(9):1050-9
[PubMed PMID: 15372245]
[29]
Rosa A, Demiati M, Cartz L, Mizon JP. Marchiafava-Bignami disease, syndrome of interhemispheric disconnection, and right-handed agraphia in a left-hander. Archives of neurology. 1991 Sep:48(9):986-8
[PubMed PMID: 1953424]
[30]
Ménégon P, Sibon I, Pachai C, Orgogozo JM, Dousset V. Marchiafava-Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions. Neurology. 2005 Aug 9:65(3):475-7
[PubMed PMID: 16087921]
[31]
Dong X, Bai C, Nao J. Clinical and radiological features of Marchiafava-Bignami disease. Medicine. 2018 Feb:97(5):e9626. doi: 10.1097/MD.0000000000009626. Epub
[PubMed PMID: 29384842]
[32]
Parmanand H T. Marchiafava-Bignami disease in chronic alcoholic patient. Radiology case reports. 2016 Sep:11(3):234-7. doi: 10.1016/j.radcr.2016.05.015. Epub 2016 Jul 9
[PubMed PMID: 27594956]
Level 3 (low-level) evidence
[33]
Staszewski J, Macek K, Stepień A. [Reversible demyelinisation of corpus callosum in the course of Marchiafava-Bignami disease]. Neurologia i neurochirurgia polska. 2006 Mar-Apr:40(2):156-61
[PubMed PMID: 16628513]
[34]
Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Internal medicine journal. 2014 Sep:44(9):911-5. doi: 10.1111/imj.12522. Epub
[PubMed PMID: 25201422]
[35]
Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol and alcoholism (Oxford, Oxfordshire). 1998 Jul-Aug:33(4):317-36
[PubMed PMID: 9719389]
[36]
Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. The Lancet. Neurology. 2007 May:6(5):442-55
[PubMed PMID: 17434099]
Level 3 (low-level) evidence
[37]
Carrilho PE, Santos MB, Piasecki L, Jorge AC. Marchiafava-Bignami disease: a rare entity with a poor outcome. Revista Brasileira de terapia intensiva. 2013 Mar:25(1):68-72
[PubMed PMID: 23887763]
[38]
Pinter G, Borbely K, Peter L. [Marchiafava-Bignami disease (Case-report)]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 2016 Jun:18(2):115-8
[PubMed PMID: 27390208]
Level 3 (low-level) evidence
[39]
O'Keeffe ST, Tormey WP, Glasgow R, Lavan JN. Thiamine deficiency in hospitalized elderly patients. Gerontology. 1994:40(1):18-24
[PubMed PMID: 8034199]
[40]
Renou P, Ducreux D, Batouche F, Denier C. Pure and acute Korsakoff syndrome due to a bilateral anterior fornix infarction: a diffusion tensor tractography study. Archives of neurology. 2008 Sep:65(9):1252-3. doi: 10.1001/archneur.65.9.1252. Epub
[PubMed PMID: 18779434]
[41]
Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA, EFNS. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European journal of neurology. 2010 Dec:17(12):1408-18. doi: 10.1111/j.1468-1331.2010.03153.x. Epub
[PubMed PMID: 20642790]
[42]
Muccio CF, De Lipsis L, Belmonte R, Cerase A. Reversible MR Findings in Marchiafava-Bignami Disease. Case reports in neurological medicine. 2019:2019():1951030. doi: 10.1155/2019/1951030. Epub 2019 Feb 6
[PubMed PMID: 30881711]